Key result
Serological screening of gilts and sows across 25 Belgian farms revealed 100% seropositivity for PCV2 and >95% for PEV, with specific herd risks identified for PPV, SIV, and PRRSV.
Cross-Sectional
Yes
Serological screening and targeted vaccination of gilts and sows can prevent reproductive disorders caused by specific viruses in swine herds.
High seroprevalence signals potential herd risks in Belgian sows; hypothesis-generating for targeted monitoring without practice change.
A serosurvey for viruses associated with reproductive disorders was conducted in 25 conventional Belgian farms. Serum antibody titers for porcine reproductive and respiratory syndrome virus (PRRSV), porcine circovirus type 2 (PCV2), porcine parvovirus (PPV), porcine enteroviruses (PEV) and swine influenza viruses (SIV) were determined in gilts and sows. All the animals were seropositive for PCV2 and >95% were seropositive for all 4 embryopathogenic PEV serotypes. Consequently, special preventive measures appear to be unnecessary for these viruses. In 1 farm, non-vaccinated gilts were found to run a risk of developing PPVinduced reproductive disorders. Vaccination against PPV could exclude this risk. In 10 farms, gilts seronegative for one or more specific SIV subtypes were introduced into a herd that had previously been infected with the same subtypes. Vaccination of gilts against SIV may prevent reproductive disorders in gilts and respiratory problems in their offspring. In 1 farm, newly purchased gilts that were possibly shedding PRRSV were introduced into a PRRSV seronegative sow herd. Serological screening prior to purchase or vaccination of the sows could have resolved this dangerous situation.
No takes yet. Share an insight, caveat, or question.
Lefebvre et al. (2009) conducted a cross-sectional in Viruses associated with reproductive disorders. Viral exposure (PRRSV, PCV2, PPV, PEV, SIV) was evaluated on Serum antibody titers for PRRSV, PCV2, PPV, PEV, and SIV. Serological screening of gilts and sows across 25 Belgian farms revealed 100% seropositivity for PCV2 and >95% for PEV, with specific herd risks identified for PPV, SIV, and PRRSV.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: